pharmaceuticals
pharmaceuticals Articles
Shares of IntelliPharmaCeutics soared after the company reported a new licensing deal with Mallinckrodt.
Published:
Last Updated:
Accelerated Pharma intends to price less than 2 million shares in the range of $8 to $10 for an initial public offering valued up to more than $21 million.
Published:
Last Updated:
The September 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short interest was mixed.
Published:
Last Updated:
Biostar Pharmaceuticals Inc. (NASDAQ: BSPM) is watching its shares nearly double on Tuesday after the company announced that it is releasing a new product line to treat respiratory irritation and...
Published:
Last Updated:
Nymox Pharmaceutical shares jumped following the announcement of positive results from its late-stage prostate cancer trial.
Published:
Last Updated:
KemPharm shares saw a solid gain on Tuesday following a key FDA approval on it treatment for attention deficit hyperactivity disorder.
Published:
Last Updated:
Shares of EpiPen maker Mylan NV (NASDAQ: MYL) rose nearly 12.5% early Monday following the company’s announcement after markets closed Friday that it had reached an agreement with the U.S....
Published:
Last Updated:
Several analysts have weighed in with higher price targets on top of their ratings for Tesaro. Its shares hit a new 52-week high on Monday.
Published:
Last Updated:
On Monday morning, Merck, Mylan and Bristol-Myers Squibb made substantial runs, either up or down.
Published:
Last Updated:
Shares of Idera Pharmaceuticals sank on Thursday after the company announced that it intends to have a secondary offering.
Published:
Last Updated:
Alnylam Pharmaceuticals saw its shares crash on Thursday after the company announced that it will be discontinuing one of its late-stage trials.
Published:
Last Updated:
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) has been on a meteoric rise over the past month. In this time the stock has gained over 150%, on what has been relatively little news for such a massive...
Published:
Last Updated:
In a new research report from Jefferies, many of the outstanding companies in pharmaceuticals and biotech space show up among the stocks to buy.
Published:
Last Updated:
Scynexis shares made a handy gain early on Thursday after the company announced the results from a couple of its mid-stage trials.
Published:
Last Updated:
24/7 Wall St. has collected several big FDA decisions and mid- to late-stage trials that should be coming up in November and December.
Published:
Last Updated: